Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Highly Accessed Research article

Assessment and comparative analysis of a rapid diagnostic test (Tubex®) for the diagnosis of typhoid fever among hospitalized children in rural Tanzania

Benedikt Ley18*, Kamala Thriemer1, Shaali M Ame2, George M Mtove34, Lorenz von Seidlein145, Ben Amos46, Ilse CE Hendriksen47, Abraham Mwambuli4, Aikande Shoo46, Deok R Kim1, Leon R Ochiai1, Michael Favorov1, John D Clemens1, Harald Wilfing8, Jacqueline L Deen14 and Said M Ali2

Author Affiliations

1 Translational Research Division, International Vaccine Institute, Seoul, Korea

2 Laboratory Division, Public Health Laboratory (Pemba) - Ivo de Carneri, Chake Chake, Tanzania

3 Amani Centre, National Institute for Medical Research, Tanga, Tanzania

4 Joint Malaria Program, Tanga, Tanzania

5 Asia Pacific Malaria Elimination Network (APMEN), Menzies School of Health Research, Casuarina, Australia

6 Teule Hospital, Muheza, Tanga, Tanzania

7 Oxford Research Unit, Mahidol University, Bangkok, Thailand

8 Biocenter, University of Vienna, Vienna, Austria

For all author emails, please log on.

BMC Infectious Diseases 2011, 11:147  doi:10.1186/1471-2334-11-147

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/11/147


Received:25 January 2011
Accepted:24 May 2011
Published:24 May 2011

© 2011 Ley et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Typhoid fever remains a significant health problem in many developing countries. A rapid test with a performance comparable to that of blood culture would be highly useful. A rapid diagnostic test for typhoid fever, Tubex®, is commercially available that uses particle separation to detect immunoglobulin M directed towards Salmonella Typhi O9 lipopolysaccharide in sera.

Methods

We assessed the sensitivity and specificity of the Tubex test among Tanzanian children hospitalized with febrile illness using blood culture as gold standard. Evaluation was done considering blood culture confirmed S. Typhi with non-typhi salmonella (NTS) and non - salmonella isolates as controls as well as with non-salmonella isolates only.

Results

Of 139 samples tested with Tubex, 33 were positive for S. Typhi in blood culture, 49 were culture-confirmed NTS infections, and 57 were other non-salmonella infections. Thirteen hemolyzed samples were excluded. Using all non - S. Typhi isolates as controls, we showed a sensitivity of 79% and a specificity of 89%. When the analysis was repeated excluding NTS from the pool of controls we showed a sensitivity of 79% and a specificity of 97%. There was no significant difference in the test performance using the two different control groups (p > 0.05).

Conclusion

This first evaluation of the Tubex test in an African setting showed a similar performance to those seen in some Asian settings. Comparison with the earlier results of a Widal test using the same samples showed no significant difference (p > 0.05) for any of the performance indicators, irrespective of the applied control group.

Keywords:
Salmonella; Tubex®; Widal; Africa; Rapid Diagnostic Test

Background

Typhoid fever remains a significant health problem in many developing countries. Estimates suggest an incidence rate of more than 21.5 million cases globally in the year 2000 [1]. Recent data from Tanzania mainland have found a strong variation of prevalence rates among blood culture positive isolates collected in local hospitals, ranging from 9% [2] to 21.4% [3] for Salmonella enterica serovar Typhi (S. Typhi), no data from Zanzibar are available to date. As the clinical picture of typhoid fever is often unspecific, misdiagnosis and insufficient or inadequate treatment are potential risks associated with the disease. In the absence of difficult-to-obtain bone marrow specimens, microbiologic culture of a blood sample is considered to be the current state-of-the art test for the diagnosis of typhoid fever even though its sensitivity may be as low as 40% [4,5]. Culture may take up to seven days and requires a well-run and equipped laboratory, which is often not available in settings with endemic typhoid fever. The widely in use Widal test provides a cost efficient alternative [6] for serological diagnosis, however its performance remains unsatisfying with sensitivity reported from Tanzania of 75% using blood culture as the gold standard and applying a cut off titer of 1:80 [7]. The test further requires the establishment of a local cut off titer prior to use which is complicated. Therefore, a rapid test with a performance comparable to that of blood culture would be desirable.

A rapid diagnostic test for typhoid fever, Tubex® is commercially available that uses particle separation to detect immunoglobulin M (IgM) directed towards Salmonella enterica serovar Typhi (S. Typhi) O9 lipopolysaccharide in patient sera. Performance of the test has previously been evaluated in a number of studies in Asia but none in Africa. Using blood culture results for comparison, we assessed the sensitivity and specificity of the Tubex test among Tanzanian children hospitalized with febrile illness and compared our results with those from previous studies.

Methods

For evaluation of the Tubex test, we used a selected subset of serum samples that was obtained for a fever surveillance study [2] from Teule Hospital in Muheza District, Tanzania. In order to accommodate the required sample size for the test validation, we included randomly selected and age-matched Salmonella enterica serotype Typhi (S. Typhi) positive serum samples from a second fever surveillance study conducted at Chake Chake Hospital in Pemba, Zanzibar. All samples were collected from children between the ages of 2 months to 14 years from 2008 to 2009.

At Teule Hospital in Muheza, sera and blood was collected for culture from children with a history of three days of fever, or a history of less than three days of fever but with at least one of the following severity criteria: respiratory distress; deep breathing; respiratory distress in combination with severe pallor; prostration; capillary refill ≥3 seconds; temperature gradient; systolic blood pressure <70 mm Hg; coma defined by Glasgow Coma Scale (GCS) ≤ 10 or Blantyre Coma Scale (BCS) ≤ 2; severe jaundice; history of two or more convulsions in the last 24 hours; blood glucose <3 mmol associated with clinical signs; neck stiffness; bulging fontanel; or oxygen saturation <90% [2].

At Chake Chake Hospital in Pemba, sera and blood was collected for culture from children with a recorded body temperature of >37.5°C for outpatients and any history of fever for inpatients. Duration of fever was not considered for study recruitment.

About 3 to 5 milliliters (ml) of blood (depending on body weight) was collected and inoculated in a BactALERT™ Pediatric-fan bottle (Teule Hospital) or a BacTec Peds PLUS ™/F bottle (Chake Chake Hospital) and incubated in the respective machine (BacT/ALERT 3D or BacTec 9050). Bacterial growth was evaluated following standard procedures.

The Tubex® test (IDL - Sweden) was conducted according to the manufacturer's instructions, which are as follows. Forty-five microliters (μl) of antigen covered particles were added to the Tubex Reaction Well Strip and 45 μl of non-hemolyzed serum was added. After two minutes of incubation time, 90 μl of magnetic antibody coated solution was added, and the strip was sealed and shaken for two minutes. The strip was then placed on a magnetic tray for five minutes, separating the particles if a positive sample had been added. The resulting color change of the solution was read and categorized on a scale from 0 to 10. The results were interpreted as positive for scores of 4 or greater and as negative for scores of 2 or below as per the manufacturer's instructions. Samples with a color corresponding to the value of 3 were interpreted as indeterminate. All blood culture isolates from individuals that matched the inclusion criteria and that were not considered a contaminant were included in the analysis.

We performed the Tubex test on non-hemolyzed serum samples from the patients of the two surveillance studies who had blood culture-confirmed S. Typhi (defined as group 1), randomly selected cases of non-Typhi serotypes of S. enterica (NTS) (defined as group 2), and randomly selected cases with other (non-Salmonellae) pathogenic bacteria (defined as group 3). Staff members performing the Tubex test were blinded to the blood culture results.

For the analysis, sensitivity (true-positive rate) was defined as the probability that the Tubex test result will be positive when there is blood culture-confirmed typhoid fever (group 1) and specificity (true-negative rate) was defined as the probability that the Tubex® test result will be negative when S. Typhi is not isolated from blood culture (groups 2 and 3). We conducted a secondary analysis using only group 3 as the control group. Comparison of test performance using different control groups was done using the Yates Chi-Square Test corrected for continuity.

We conducted a literature review in order to compare our findings with those from previous studies. We included studies of the Tubex test, which were identified by directly searching the MEDLINE database through PubMed. All articles since the first publication of the test [8] were included. We also conducted a supplementary search of references in retrieved articles. Abstracts were reviewed, and if relevant, the article was included.

A comparison of performance of the Tubex® test with earlier published Widal test results obtained from the same samples was done using McNemar's Test for Correlated Proportions http://faculty.vassar.edu/lowry/VassarStats.html. webcite

The fever surveillance studies at Chake-Chake and Teule Hospitals were approved by their respective local ethical review boards (Tanzania and Zanzibar), as well as by the International Vaccine Institute's Institutional Review Board. Written informed consent was obtained from legal guardians of all participants prior to any sample or data collection.

Results

A total of 139 samples were tested with Tubex. Thirty-three were found positive for S. Typhi in blood culture (group 1), 49 were culture-confirmed non-S. Typhi (NTS) infection (group 2), and 57 were other non-Salmonella infections that were not contaminants (group 3). Thirteen hemolyzed samples were excluded (Figure 1).

thumbnailFigure 1. Specimen assembly.

Of the 33 blood culture-positive S. Typhi cases, 26 had a positive Tubex result and were considered as true positives. Of the 106 blood culture confirmed NTS and non-salmonella cases (groups 2 and 3), 94 yielded a negative Tubex result and were considered as true negatives. Considering only the 57 non-Salmonella cases (group 3) as controls, resulted in 54 true negative cases.

Using groups 2 and 3 as controls showed a sensitivity of 79% and a specificity of 89% (Table 1). The same analysis was repeated excluding NTS from the pool of controls and showed 79% and 97% for sensitivity and specificity, respectively. There was no significant difference in the test performance using the two different control groups (all were p > 0.05 using the Chi square test).

Table 1. Performance of Tubex® using group 1 as true positives and two different control groups as true negatives

A total of 14 articles were retrieved and evaluated for inclusion into the review. All of the reported studies were performed in Asia; none in Africa. A total of six articles were excluded: two evaluated the test for non-typhoidal Salmonella [9] or S. Paratyphi [10], three did not evaluate the sensitivity and specificity of the test [11-13], and one was a letter to the editor [14]. Thus, eight publications were included in the review (Table 2). Five of the included articles reported findings of test performance that were similar to our results [15-19]. Two publications showed considerably lower sensitivity and specificity [20,6], and one reported higher values [8] (Table 2).

Table 2. Comparison of the performance of the Tubex® test from published reports

Discussion

We found Tubex has a sensitivity of 79% using either control group (95%CI: 52-81% for groups 2 and 3, and 62-90% for group 3 only) and a specificity of 89-97% (95%CI: 81-94% for groups 2 and 3 and 85-99% for group 3 only) irrespective of control group. To our knowledge, this is the first evaluation of the test in an African population. Our results were similar to those observed in previous studies (five out of eight studies) in Asia assessing the performance of the test [15-19], though Kawano et al. [17] and House et al. [19] used a lower cut-off titer than is recommended in the manual. In contrast, two studies [20,6] found the performance of Tubex to be poorer than our findings, despite using a similar cut-off value, gold standard, and inclusion criteria. The extremely good performance of Tubex observed by Lim et al. [8] has not been reproduced since.

An important limitation of this study is that the sera are combined from two different patient populations and the purposeful selection of samples included in the three groups. During the preparation of the study, we calculated the sample sizes of true positive sera and true negative sera that are required for validation of the Tubex test and for comparison with the Widal test performance. The number of true positive sera from either hospital alone was insufficient for the validation. Thus, we included S. Typhi blood culture-confirmed sera from Pemba. Analysis of the results by hospital was not possible because of insufficient sample size.

In a sub-analysis in assessing cross reactivity with NTS, blood culture-confirmed NTS cases were considered as true positives, and all other positive isolates, excluding S. Typhi, were considered as true negatives. In this sub-analysis Tubex had a sensitivity of 18% and a specificity of 95% (analysis not shown).

Comparison with a Widal test that was earlier conducted using the same samples [7] revealed no significant difference (p > 0.05) for any of the performance indicators, irrespective of the applied control group. But compared to the Widal test, Tubex is easier and quicker to perform. The Widal test requires 16 - 20 hours until the results are obtained while the complete procedure for the Tubex test is approximately 20 minutes. Tubex is more expensive at approximately 2.15 USD per test compared to <0.80 USD per test for the Widal tube agglutination test [6].

Interpreting the Tubex test results was found to be difficult and the results were prone to inter - reader variation. Assessing the color change according to the provided color scale requires experience and standardized good lighting conditions. The Tubex test can only be applied to non-hemolyzed and non-icteric serum samples, thus limiting its general application. However Tam et al. [12] have described a method that includes a washing step and thereby addresses the problem of turbid serum. This method requires double the amount of antigen-coated particles as well as glycine buffered saline (GBS), thereby increasing the price per sample to approximately 4.50 USD and reducing its feasibility as an easy-to-perform test. While neither of the tests can be performed by untrained staff, interpretation of results is considered easier for the Widal test compared to Tubex.

Conclusion

The advantages of Tubex over the Widal test and the gold standard of blood culture is the short time it requires to obtain a result, and it does not require establishing a local cut-off value as with the Widal. In settings that can afford the relatively high cost of Tubex and that require instant individual diagnoses to support the clinical diagnosis of typhoid fever, Tubex is superior to the Widal tube agglutination test. For screening and surveillance purposes, as well as in settings with limited financial and technical resources, the Widal tube agglutination test is a possible alternative that can provide a similar performance as Tubex at a lower cost though it requires more time. Our evaluation of Tubex showed that any result must be handled with precaution. Results should be considered as indicative, not confirmatory. The test may be used to exclude disease though. In conclusion, the need for a reliable, fast, cheap, and easy-to-apply rapid diagnostic test for typhoid fever remains in high demand.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

BL performed the TUBEX test, analyzed results and wrote the manuscript, KT performed TUBEX tests, literature search and contributed to the manuscript, SMA supervised the laboratory work in Pemba, GM was in charge of the implementation and study management in Teule, LvS provided scientific support to study staff and contributed to the manuscript, BA supervised the laboratory work in Teule, ICEH was involved in the clinical care of patients, AM was in charge of data management, AS performed blood culture procedures, DRK performed statistical analyses, RLO provided scientific support to the manuscript, MF provided scientific support to the manuscript, JDC provided scientific support to the manuscript, HW provided scientific support to the manuscript, JLD provided major scientific support to the manuscript and was involved in the clinical care of patients, SMA provided scientific support to the manuscript and the study in Pemba. All authors have read and approved the final manuscript.

Acknowledgements

We thank Hugh Reyburn of the London School of Hygiene and Tropical Medicine who supported this project and provided his scientific expertise. We also thank Rajabu Malahiyo and Steven Magesa for their support.

This work was supported by a grant from the Korea International Cooperation Agency (KOICA) and the Swedish International Development Cooperation Agency (SIDA) to the International Vaccine Institute.

This study is published with permission from the Director General of the Tanzanian National Institute for Medical Research, Dar-Es-Salaam. We are grateful to the patients and their parents who made this work possible. We thank all of the technical staff and research assistants who were involved in the study.

References

  1. Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever.

    Bulletin of the World Health Organization 2004, 82(5):346-353. PubMed Abstract | PubMed Central Full Text OpenURL

  2. Mtove G, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, Kimera J, Mallahiyo R, Kim DR, Ochiai RL, Clemens JD, Reyburn H, Magesa S, Deen JL: Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies.

    PLoS One 2010, 5(2):e9244. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  3. Crump JC, Ramadhani HO, Morrisey AB, Saganda W, Mwako MS, Yang LY, Chow SC, Morpeth SC, Reyburn H, Njau BN, Shaw AV, Diefenthal HC, Shao JF, Bartett JA, Maro VP: Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.

    CID 2011, 52(3):341-348. Publisher Full Text OpenURL

  4. Parry CM, Hien TT, Dougan G, White N, Farrar JJ: Typhoid Fever.

    The New England Journal of Medicine 2002, 347(22):1770-1782. PubMed Abstract | Publisher Full Text OpenURL

  5. Wilke A, Ergonul O, Bayar B: Widal Test in Diagnosis of Typhoid Fever in Turkey.

    Clin Diagn Lab Immunol 2002, 9(4):938-41. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  6. Sur D, Manna B, Sen B, Deb AK, Deen JL, Wain J, von Seidlein L, Ochiai RL, Clemens JD, Bhattacharya SK: Evaluation of a new-generation serologic test for the diagnosis of typhoid fever: data from a community - based surveillance in Calcutta, India.

    Diagnostic Microbiology and Infectious Disease 2006, 56:359-365. PubMed Abstract | Publisher Full Text OpenURL

  7. Ley B, Mtove G, Thriemer K, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, Shoo A, Malahiyo R, Ame S, Kim DR, Ochiai RL, Clemens JD, Reyburn H, Wilfing H, Magessa S, Deen JL: Evaluation of the Widal tube agglutination test for the diagnosis of typhoid fever among children admitted to a rural hospital in Tanzania and a comparison with previous studies.

    BMC 2010, 10:180. OpenURL

  8. Lim PL, Tam FC, Cheong YM, Jegathesan M: One-step 2-minute test to detect typhoid-specific antibodies based on particle separation in tubes.

    J Clin Microbiol 1998, 36(8):2271-8. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  9. Oracz G, Feleszko W, Golicka D, Maksymiuk J, Klonowska A, Szajewska H: Rapid diagnosis of acute Salmonella gastrointestinal infection.

    Clin Infect Dis 2003, 36(1):112-5. PubMed Abstract | Publisher Full Text OpenURL

  10. Tam FC, Wang M, Dong B, Leung DT, Ma CH, Lim PLL: New rapid test for paratyphoid a fever: usefulness, cross-detection, and solution.

    Diagn Microbiol Infect Dis 2008, 62(2):142-50. PubMed Abstract | Publisher Full Text OpenURL

  11. Tam FC, Lim PL: The TUBEX typhoid test based on particle-inhibition immunoassay detects IgM but not IgG anti-O9 antibodies.

    J Immunol Methods 2003, 282(1-2):83-91. PubMed Abstract | Publisher Full Text OpenURL

  12. Tam FC, Leung DT, Ma CH, Lim PL: Modification of the TUBEX typhoid test to detect antibodies directly from haemolytic and whole blood.

    Journal of Medical Microbiology 2008, 57:1349-1353. PubMed Abstract | Publisher Full Text OpenURL

  13. Tam FC, Ling TK, Wong KT, Leung DT, Chan RC, Lim PL: The TUBEX test detects not only typhoid-specific antibodies but also soluble antigens and whole bacteria.

    J Med Microbiol 2008, 57(Pt 3):316-23. PubMed Abstract | Publisher Full Text OpenURL

  14. Feleszko W, Maksymiuk J, Oracz G, Golicka D, Szajewska H: The TUBEX typhoid test detects current Salmonella infections.

    J Immunol Methods 2004, 285(1):137-8. PubMed Abstract | Publisher Full Text OpenURL

  15. Rahman M, Siddique AK, Tam FC, Sharmin S, Rashid H, Iqbal A, Ahmed S, Nair GB, Chaignat CL, Lim PL: Rapid detection of early typhoid fever in endemic community children by the TUBEX O9-antibody test.

    Diagn Microbiol Infect Dis 2007, 58(3):275-81. PubMed Abstract | Publisher Full Text OpenURL

  16. Dong B, Galindo CM, Shin E, Acosta CJ, Page AL, Wang M, Kim D, Ochiai RL, Park J, Ali M, Seidlein LV, Xu Z, Yang J, Clemens JD: Optimizing typhoid fever case definitions by combining serological tests in a large population study in Hechi City, China.

    Epidemiol Infect 2007, 135(6):1014. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  17. Kawano RL, Leano SA, Agdamag DMA: Comparison of serological Test Kits for Diagnosis of Typhoid Fever in the Philippines.

    Journal of Clinical Microbiology 2007, 45(1):246-247. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  18. Olsen SJ, Pruckler J, Bibb W, Thanh NTM, Trinh TM, Minh NT, Sivapalsingam S, Gupta A, Phuong PT, Chinh NT, Chau NV, Cam PD, Mintz ED: Evaluation of Rapid Diagnostic Test for Typhoid Fever.

    Journal of Clinical Microbiology 2004, 42(5):1885-1889. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  19. House D, Wain J, Ho VA, Diep TS, Chinh NT, Bay PV, Vinh H, Duc M, Parry CM, Dougan G, White NJ, Hien TT, Farrar JJ: Serology Of Typhoid Fever in an Area of Endemicity and Its Relevance to Diagnosis.

    Journal of Clinical Microbiology 2001, 39(2):1002-1007. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  20. Naheed A, Ram PK, Brooks WA, Mintz ED, Hossain MA, Parsons MM, Luby SP, Breiman RF: Clinical value of Tubex® and Typhidot rapid diagnostic tests for typhoid fever in an urban community clinic in Bangladesh.

    Diagn Microbiol Infect Dis 2008, 61(4):381-6. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/11/147/prepub